Paramedics with extended skills can provide a safe and effective alternative to standard ambulance transfer and hospital treatment for older people with a minor injury or illness, finds a study published online today.
Health Canada is reminding consumers who wear soft contact lenses about the recall of COMPLETE All-In-One Contact Lens Care Solution. Adverse reaction reports to Health Canada of potentially serious eye problems since the recall was announced May_30, 2007 suggest that consumers may still be using the product.
The sixth annual Science and Leadership Symposium for Women and Heart Disease, scheduled for Oct. 6 through Oct. 10 at Mayo Clinic, opens on the heels of timely research furthering the concern that women are less likely than men to receive heart care.
There have been improvements in cancer survival in Northern Ireland between 1993 and 2004, according to a new report from the Northern Ireland Cancer Registry (NICR).
The California Medical Association criticized President Bush’s veto of a bill to extend health coverage to children, calling the move a huge setback for access to health care for millions of children.
A new scientific review released today by the Department of Health & Human Services’s (HHS) Agency for Healthcare Research and Quality (AHRQ) concludes that evidence of benefit is lacking for many common ways of treating osteoarthritis of the knee, including popular dietary supplement ingredients, a common surgical procedure, and injected preparations.
About 14,000 students from various city schools brushed their teeth together at Nehru stadium here to enter the Guinness Book of World Records.
If you want to live longer, lose weight — so say various studies. But, there’s another, more effective way to increase your own, your spouse’s and your children’s longevity, without the sweat or the bland food — it’s staying married.
WHO today releases its first guide on planning palliative care services for people living with advanced stages of cancer. The guide, which is based on consultations with more than 70 leading cancer experts in the world, has identified highly effective low-cost public health models to care for terminally ill cancer patients, especially in developing countries.
Health Canada is advising consumers that it has stopped the sale of the anti-inflammatory drug Prexige (lumiracoxib) in Canada and will cancel the drug’s market authorization due to the potential for serious liver-related adverse events.